Skip to main content
logo
Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
2.570
+0.180 (7.53%)
Jun 26, 2026, 4:10 PM AEST

Revenue by Segment

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16
Women's Health
178.37M142.83M61.89M10.57M7.53M
Women's Health Growth
24.88%130.78%485.69%40.35%-
Dermatology
154.09M174.86M56.99M92.21M268.41M
Dermatology Growth
-11.88%206.81%-38.19%-65.64%-
International
75.64M70.71M64.70M54.37M42.76M
International Growth
6.97%9.29%19.01%27.15%0.95%
Metrics Contract Services (MCS)
----82.09M
Metrics Contract Services (MCS) Growth
-----0.89%
Total
408.10M388.40M183.59M157.15M400.78M
Total Growth
5.07%111.56%16.82%-60.79%-12.30%

Revenue by Geography

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17 Jun '16
United States
338.85M322.13M124.46M103.27M358.02M
United States Growth
5.19%158.81%20.53%-71.16%-13.65%
Australia and New Zealand
41.94M40.34M41.20M33.70M29.96M
Australia and New Zealand Growth
3.97%-2.09%22.24%12.48%-
Canada
19.77M13.37M9.93M9.06M5.45M
Canada Growth
47.92%34.62%9.62%66.15%-
Europe and Other
4.69M7.13M3.60M6.25M2.18M
Europe and Other Growth
-34.21%98.00%-42.36%186.03%-
Asia
2.85M5.44M4.40M4.88M5.16M
Asia Growth
-47.61%23.78%-9.86%-5.54%7.47%
Total
408.10M388.40M183.59M157.15M400.78M
Total Growth
5.07%111.56%16.82%-60.79%-12.30%